Cellebrite’s Q1 2026 Revenue Jumps 15% - geneonline.com

Skip to content 2026-05-14 | Cellebrite’s Q1 2026 Revenue Jumps 15% by GOAI Share To FacebookTwitterLinkedInCopy Link Cellebrite announced its financial results for the first quarter of 2026, revealing key figures regarding revenue, profitability, and forward-looking projections. The company highlighted its performance in various sectors and provided an outlook for the upcoming financial periods. Specifically, Cellebrite reported a revenue increase of 15% compared to the first quarter of 2025, driven by growth in both its software and hardware segments. Gross profit margins remained stable at 68%, consistent with the previous year. Operating expenses saw a slight increase due to investments in research and development, as well as sales and marketing initiatives aimed at expanding the company’s global footprint. Net income for the quarter was $12 million, a 10% increase year-over-year. Looking ahead, Cellebrite projects continued revenue growth of approximately 12-14% for the full fiscal year 2026, with an emphasis on expanding its cloud-based solutions and enhancing its product offerings to meet evolving customer needs. Newsflash | Powered by GeneOnline AI Source: GO-AI-ne1 For any suggestion and feedback, please contact us. Date: May 14, 2026 ©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com Author GOAI Related Post LATEST LMU Study: Midbrain Rhythm Identified as Potential Marker Differentiating Dreaming from Deep Sleep 2026-05-29 Brain Mapping Study Identifies Waste Removal Pathways, Potential Link to Alzheimer’s Disease 2026-05-29 Molecular Simulations Identify Two Potential Drug Candidates for Tuberculosis 2026-05-29 Shareholders of Record May 7, 2026, Eligible to Vote at June 18, 2026 Meeting 2026-05-29 Ramaco Resources CEO Randall W. Atkins Discusses Critical Minerals and Energy on CNBC’s “Morning Call” 2026-05-29 A10 Global Fund, L.P. Increases Holdings in Sigma Lithium Corporation 2026-05-29 Autozi Internet Technology H1 2026 Gross Profit Rises 21.4% to RMB 93.8 Million 2026-05-29 READ MORE EVENT 2026-05-29 ASCO 2026 (Major Oncology Clinical Data) Chicago, Illinois 2026-06-22 BIO International Convention (Global Biotech Showcase) Boston, Massachusetts 2026-06-25 Medical Taiwan 2026 (Devices, Diagnostics, Digital & Smart Health) Taipei, Taiwan 2026-06-25 ASCO Breakthrough 2026 (Next-Gen Oncology Innovation) Singapore 2026-07-08 ISSCR (Regenerative Medicine &Cell Therapy) Montreal, Canada 2026-07-15 BIO Asia-Taiwan 2026 (APAC Biotech & Investment) Taipei, Taiwan SEE MORE Newsletter Subscribe to receive updates. SIGN UP Facebook Youtube Twitter Linkedin About Explore More © 2026 GeneOnline Privacy Policy | Terms of Service Subscribe to our newsletter and dive into the world of biopharma with us. SIGN UP GeneOnline site use cookies and similar technologies. By using GeneOnline site, you are agreeing to our revised Privacy Policy and Terms of Service. AddToAny More…